Company Overview and News

Maxim (MXIM) Offers Design Efficiency With Digital Amplifiers

2018-05-16 zacks
Reportedly Maxim Integrated Products, Inc.’s (MXIM - Free Report) digital audio amplifiers are gaining traction, courtesy of their audio quality enhancing ability. MAX98357 and MAX98358 provide 3.2W of Class AB audio performance with Class D efficiency in audio quality. With these amplifiers, designers are now being able to reduce their solution size which was difficult with analog amplifiers as they would affect the overall size of the solution.

46 'Safer' Dividend Nasdaq Equities Paced By Comcast Gain And Vodafone Yield For May

2018-05-07 seekingalpha
46 of 52 Nasdaq Index dividends were presumed "safer" because they showed positive one-year returns and free cash flow yields greater than dividend yields as of 5/4/17.

Here Are 52 Top NASDAQ Stocks By Yield, Upside And Gains For May

2018-05-07 seekingalpha
"The Nasdaq-100 Index includes 100 of the largest domestic and international non-financial companies listed on The Nasdaq Stock Market based on market capitalization." 52 pay dividends.

Maxim (MXIM) Earnings and Revenues Beat Estimates in Q3

2018-04-30 zacks
Maxim Integrated Products, Inc. (MXIM - Free Report) reported third-quarter fiscal 2018 adjusted earnings of 73 cents per share, surpassing the Zacks Consensus Estimate by 4 cents. Also, earnings increased 13% sequentially and 31% from the year-ago quarter.

NXP Semiconductors: Undervalued Busted Merger

2018-04-30 seekingalpha
NXP is a high quality automotive focused analog semiconductor company that trades at a significant discount to the sector due to its status as a busted M&A trade.

Competing In A Mixed Signal World: Cirrus Logic's Competition

2018-04-27 seekingalpha
Understanding and watching how Cirrus penetrates Qualcomm mixed signal offerings is still important, but much less than in past years.

Maxim Integrated Products (MXIM) Q3 2018 Results - Earnings Call Transcript

2018-04-27 seekingalpha
Good day, ladies and gentlemen, and welcome to the Maxim Integrated Third Quarter of Fiscal 2018 Conference Call. At this time, all participants are in a listen-only mode. Later, we'll conduct a question-and-answer session and instructions will be given at that time. As a reminder, today's program is being recorded.

Maxim Integrated Products, Inc. 2018 Q3 - Results - Earnings Call Slides

2018-04-27 seekingalpha
The following slide deck was published by Maxim Integrated Products, Inc. in conjunction with their 2018 Q3 earnings call.

Tech Stocks Earnings on Apr 26: MSFT, INTC, VRSN and MXIM

2018-04-25 zacks
The Q1 earnings cycle is in full swing, with a number of tech companies, including Facebook and Amazon (AMZN - Free Report) , slated to report their quarterly numbers this week. According to the Earnings Preview dated Apr 20, technology, along with the finance sector, will bring in more than 40% of the S&P 500 index’s total earnings this year. Per the report, Q1 total earnings for the tech sector are projected to be up 20.

Can a Diverse Portfolio Lift Maxim's (MXIM) Earnings in Q3?

2018-04-23 zacks
Maxim Integrated Products Inc. (MXIM - Free Report) is set to report third-quarter fiscal 2018 results on Apr 26. The company topped the Zacks Consensus Estimate in the trailing four quarters, with an average beat of 4.99%. Last quarter, Maxim delivered a positive earnings surprise of 1.56%. Earnings of 65 cents per share increased 42% from the year-ago quarter and 9% sequentially. Revenues increased 13% year over year and 8.

Wait for Volatility to Subside Before Buying Broadcom Ltd Stock

2018-03-21 investorplace
I have to thank Broadcom Ltd (NASDAQ:AVGO). In August of last year, I discussed the contrarian opportunity in Qualcomm, Inc. (NASDAQ:QCOM). At the time, QCOM was under heavy pressure, but I maintained that the selloff was excessive. But out of nowhere, Broadcom’s takeover bid for Qualcomm drove up sentiment for both Broadcom stock and its target.

Broadcom Not Exactly Back To Square One

2018-03-20 seekingalpha
Broadcom's fiscal first quarter results should underscore that the company still has a good business, with or without Qualcomm.

Tops Of 44 'Safer' Dividend Nasdaq Equities: Comcast By Gain; Vodafone By Yield For March

2018-03-18 seekingalpha
46 of 52 NASDAQ Index dividends were presumed "safer" because they showed positive one-year returns and free cash flow yields greater than dividend yields as of 3/15/17.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: 57772K101